HIMS · Hims & Hers Health, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.00M | $526.92M | $271.88M | $148.76M |
| Cost of Revenue | $614.26M | $303.38M | $157.05M | $118.19M | $67.38M | $39.31M |
| Gross Profit | $1.73B | $1.17B | $714.95M | $408.72M | $204.49M | $109.45M |
| R&D | - | - | - | - | - | - |
| SG&A | $272.72M | $167.77M | $129.88M | $98.19M | $183.63M | $65.61M |
| Total Operating Expenses | $1.63B | $1.11B | $744.40M | $477.42M | $319.54M | $124.59M |
| D&A | $54.50M | $17.09M | $9.52M | $7.47M | $4.08M | $1.06M |
| Operating Income | $105.61M | $61.90M | ($29.45M) | ($68.70M) | ($115.04M) | ($4.79M) |
| Interest Expense | - | - | - | - | $0 | $10.0K |
| Income Tax | ($4.44M) | ($54.33M) | $1.98M | ($31.0K) | ($3.14M) | $127.0K |
| Net Income | $128.37M | $126.04M | ($23.55M) | ($65.68M) | ($107.66M) | ($3.05M) |
| EPS - Basic | $0.57 | $0.58 | ($0.11) | ($0.32) | ($0.58) | ($0.51) |
| EPS - Diluted | $0.51 | $0.53 | ($0.11) | ($0.32) | ($0.58) | ($0.51) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $228.62M | $220.58M | $96.66M | $46.77M | $71.78M | $1.06M |
| Accounts Receivable | $32.10M | $6.10M | $6.70M | $3.90M | $1.10M | - |
| Inventory | $80.13M | $64.43M | $22.46M | $21.56M | $13.56M | - |
| Accounts Payable | $143.28M | $91.18M | $43.07M | $32.36M | $19.64M | $48.2K |
| Current Assets | $767.64M | $395.83M | $265.05M | $216.59M | $269.90M | $1.11M |
| Total Assets | $2.15B | $707.54M | $441.19M | $366.34M | $420.58M | $205.63M |
| Current Liabilities | $404.43M | $221.37M | $88.47M | $47.94M | $79.22M | $4.90M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $1.61B | $230.82M | $97.16M | $54.60M | $85.97M | $12.09M |
| Stockholders' Equity | $540.93M | $476.72M | $344.03M | $311.74M | $334.62M | $5.00M |
| Retained Earnings | ($113.77M) | ($242.14M) | ($368.18M) | ($344.63M) | ($278.95M) | ($1.90M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $300.01M | $251.08M | $73.48M | ($26.53M) | ($34.41M) | ($777.1K) |
| Investing Cash Flow | ($1.02B) | ($19.05M) | ($12.11M) | $34.70M | ($156.27M) | $325.0K |
| Financing Cash Flow | $729.62M | ($107.84M) | ($11.47M) | ($33.13M) | $235.04M | $47.74M |
| CapEx | $242.60M | $52.80M | - | - | - | - |
| Free Cash Flow | $57.41M | $198.28M | - | - | - | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% |
| Operating margin | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% | -3.2% |
| EBITDA margin | 6.8% | 5.3% | -2.3% | -11.6% | -40.8% | -2.5% |
| Net margin | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% | -2.0% |
| Free cash flow margin | 2.4% | 13.4% | - | - | - | - |
| FCF / Net income | 0.45 | 1.57 | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 11.6% | 11.4% | 14.9% | 18.6% | 67.5% | 44.1% |
| Effective tax rate | -3.6% | -75.8% | - | - | - | - |
| Return on assets | 6.0% | 17.8% | -5.3% | -17.9% | -25.6% | -1.5% |
| Return on equity | 23.7% | 26.4% | -6.8% | -21.1% | -32.2% | -61.0% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 1.90 | 1.79 | 3.00 | 4.52 | 3.41 | 0.23 |
| Quick ratio | 1.70 | 1.50 | 2.74 | 4.07 | 3.24 | 0.23 |
| Cash ratio | 0.57 | 1.00 | 1.09 | 0.98 | 0.91 | 0.22 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | -479.2x |
| Equity multiplier | 3.98 | 1.48 | 1.28 | 1.18 | 1.26 | 41.13 |
| Liabilities / Assets | 0.75 | 0.33 | 0.22 | 0.15 | 0.20 | 0.06 |
| Efficiency | ||||||
| Asset turnover | 1.09 | 2.09 | 1.98 | 1.44 | 0.65 | 0.72 |
| Inventory turnover | 7.67 | 4.71 | 6.99 | 5.48 | 4.97 | - |
| Days sales outstanding | 5d | 2d | 3d | 3d | 1d | - |
| Days inventory outstanding | 48d | 78d | 52d | 67d | 73d | - |
| Days payable outstanding | 85d | 110d | 100d | 100d | 106d | 0d |
| Cash conversion cycle | -33d | -31d | -45d | -31d | -31d | - |
| Valuation | ||||||
| P / E | 63.7x | 45.6x | - | - | - | - |
| P / B | 15.5x | 12.0x | 5.4x | 4.2x | 3.7x | 103.2x |
| P / S | 3.6x | 3.9x | 2.1x | 2.5x | 4.5x | 3.5x |
| EV / EBITDA | 50.9x | 69.7x | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 59.0% | 69.3% | 65.5% | 93.8% | 82.8% | 80.2% |
| Revenue CAGR (3y) | 64.5% | 75.8% | 80.3% | 85.5% | - | - |
| Revenue CAGR (5y) | 73.6% | 78.0% | - | - | - | - |
| Gross profit growth (YoY) | 47.8% | 64.1% | 74.9% | 99.9% | 86.8% | 145.4% |
| Operating income growth (YoY) | 70.6% | - | 57.1% | 40.3% | -2300.8% | 93.6% |
| Net income growth (YoY) | 1.8% | - | 64.1% | 39.0% | -3430.9% | 95.8% |
| EPS growth (YoY) | -3.8% | - | 65.6% | 44.8% | -13.7% | 75.4% |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | -71.0% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 13.5% | 38.6% | 10.4% | -6.8% | 6592.4% | -0.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Geographic
$2.35B totalUS$2.21B · 94.3%
Non Us$133.99M · 5.7%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.46
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
4/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Services-Offices & Clinics of Doctors of Medicine
Comparing Hims & Hers Health against the 5 most active filers in the same SIC group.